Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration

PLoS Medicine

Volumn 4, Issue 10, 2007, Pages 1628-1654

  Vandenbroucke, Jan P ^a   Von Elm, Erik ^b,c   Altman, Douglas G ^d   Gøtzsche, Peter C ^e   Mulrow, Cynthia D ^f   Pocock, Stuart J ^g   Poole, Charles ^h   Schlesselman, James J ⁱ   Egger, Matthias ^b,j  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Rigshospitalet   (Denmark)

^f UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h IL   (United States)

ⁱ UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^j UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CHECKLIST; DATA ANALYSIS; EMPIRICAL RESEARCH; EPIDEMIOLOGY; GROUP DYNAMICS; INTERNET; MEASUREMENT; MEDICAL RESEARCH; OBSERVATIONAL STUDY; PATIENT; QUALITY CONTROL; SENSITIVITY ANALYSIS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; METHODOLOGY; OBSERVATION; PRACTICE GUIDELINE; PUBLISHING; REVIEW; STANDARD;

CASE-CONTROL STUDIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGIC RESEARCH DESIGN; GUIDELINES AS TOPIC; OBSERVATION; PUBLISHING;

EID: 35649019787     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040297     Document Type: Article

References (237)

1. Glasziou P, Vandenbroucke JP, Chalmers I (2004) Assessing the quality of research. BMJ 328: 39-41.
2. Funai EF, Rosenbush EJ, Lee MJ, Del Priore G (2001) Distribution of study designs in four major US journals of obstetrics and gynecology. Gynecol Obstet Invest 51: 8-11.
3. Scales CD Jr., Norris RD, Peterson BL, Preminger GM, Dahm P (2005) Clinical research and statistical methods in the urology literature. J Urol 174: 1374-1379.
4. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, et al. (2004) Issues in the reporting of epidemiological studies: a survey of recent practice. BMJ 329: 883.
5. Tooth L, Ware R, Bain C, Purdie DM, Dobson A (2005) Quality of reporting of observational longitudinal research. Am J Epidemiol 161: 280-288.
6. von Elm E, Altman DG, Egger M, Gøtzsche PC, Pocock SJ, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Med e296. doi:10.1371/journal.pmed.0040296.
7. Mihailovic A, Bell CM, Urbach DR (2005) Users' guide to the surgical literature. Case-control studies in surgical journals. Can J Surg 48: 148-151.
8. Rushton L (2000) Reporting of occupational and environmental research: use and misuse of statistical and epidemiological methods. Occup Environ Med 57: 1-9.
9. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46.
10. Moonesinghe R, Khoury MJ, Janssens AC (2007) Most published research findings are false - but a little replication goes a long way. PLoS Med 4: e28. doi:10.1371/journal.pmed.0040028
11. Jenicek M (1999) Clinical Case Reporting. Evidence-Based Medicine. Oxford: Butterworth-Heinemann. 117 pp.
12. Vandenbroucke JP (2001) In defense of case reports and case series. Ann Intern Med 134: 330-334.
13. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, et al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138: 40-44.
14. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, et al. (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391.
15. Ioannidis JP, Gwinn M, Little J, Higgins JP, Bernstein JL, et al. (2006) A road map for efficient and reliable human genome epidemiology. Nat Genet 38: 3-5.
16. Rodrigues L, Kirkwood BR (1990) Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls. Int J Epidemiol 19: 205-213.
17. Rothman KJ, Greenland S (1998) Case-Control Studies. In: Rothman KJ, Greenland S editors. Modern epidemiology. 2nd ed: Lippincott Raven. pp. 93-114.
18. Forand SP (2004) Leukaemia incidence among workers in the shoe and boot manufacturing industry: a case-control study. Environ Health 3: 7.
19. Benson K, Hartz AJ (2000) A comparison of observational studies and randomized, controlled trials. N Engl J Med 342: 1878-1886.
20. Gøtzsche PC, Harden A Searching for non-randomised studies. Draft chapter 3. Cochrane Non-Randomised Studies Methods Group, 26 July 2002. Available: http://www.cochrane.dk/nrsmg. Accessed 10 September 2007.
21. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, et al. (2007) Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med 146: 87-95.
22. American Journal of Epidemiology (2007) Information for authors. Available: http://www.oxfordjournals.org/aje/for_authors/index.html. Accessed 10 September 2007.
23. Haynes RB, Mulrow CD, Huth EJ, Altman DG, Gardner MJ (1990) More informative abstracts revisited. Ann Intern Med 113: 69-76.
24. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, et al. (1994) Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. CMAJ 150: 1611-1615.
25. Hartley J, Sydes M (1996) Which layout do you prefer? An analysis of readers' preferences for different typographic layouts of structured abstracts. J Inform Sci 22: 27-37.
26. Viner RM, Cole TJ (2005) Adult socioeconomic, educational, social, and psychological outcomes of childhood obesity: a national birth cohort study. BMJ 330: 1354.
27. McCauley J, Kern DE, Kolodner K, Dill L, Schroeder AF, et al. (1995) The "battering syndrome": prevalence and clinical characteristics of domestic violence in primary care internal medicine practices. Ann Intern Med 123: 737-746.
28. McEvoy SP, Stevenson MR, McCartt AT, Woodward M, Haworth C, et al. (2005) Role of mobile phones in motor vehicle crashes resulting in hospital attendance: a case-crossover study. BMJ 331: 428.
29. Vandenbroucke JP (1991) Prospective or retrospective: what's in a name? BMJ 302: 249-250.
30. Last JM (2000) A Dictionary of Epidemiology. New York: Oxford University Press.
31. Miettinen OS (1985) Theoretical Epidemiology: principles of occurrence research in medicine. New York: Wiley. pp. 64-66.
32. Rothman KJ, Greenland S (1998) Types of Epidemiologic Studies. In: Rothman KJ, Greenland S editors. Modern epidemiology. 2nd ed: Lippincott Raven. pp. 74-75.
33. MacMahon B, Trichopoulos D (1996) Epidemiology, principles and methods. 2nd ed. Boston: Little, Brown. 81 p.
34. Lilienfeld AM (1976) Foundations of Epidemiology. New York: Oxford University Press.
35. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, et al. (1995) Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332: 912-917.
36. Goodman KJ, O'Rourke K, Day RS, Wang C, Nurgalieva Z, et al. (2005) Dynamics of Helicobacter pylori infection in a US-Mexico cohort during the first two years of life. Int J Epidemiol 34: 1348-1355.
37. Altman DG, De Stavola BL, Love SB, Stepniewska KA (1995) Review of survival analyses published in cancer journals. Br J Cancer 72: 511-518.
38. Cerhan JR, Wallace RB, Folsom AR, Potter JD, Munger RG, et al. (1993) Transfusion history and cancer risk in older women. Ann Intern Med 119: 8-15.
39. Beane Freeman LE, Dennis LK, Lynch CF, Thorne PS, Just CL (2004) Toenail arsenic content and cutaneous melanoma in Iowa. Am J Epidemiol 160: 679-687.
40. Canto JG, Allison JJ, Kiefe CI, Fincher C, Farmer R, et al. (2000) Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med 342: 1094-1100.
41. Metzkor-Cotter E, Kletter Y, Avidor B, Varon M, Golan Y, et al. (2003) Long-term serological analysis and clinical follow-up of patients with cat scratch disease. Clin Infect Dis 37: 1149-1154.
42. Johnson ES (1990) Bias on withdrawing lost subjects from the analysis at the time of loss, in cohort mortality studies, and in follow-up methods. J Occup Med 32: 250-254.
43. Berkson J (1946) Limitations of the application of fourfold table analysis to hospital data. Biom Bull 2: 53.
44. Feinstein AR, Walter SD, Horwitz RI (1986) An analysis of Berkson's bias in case-control studies. J Chronic Dis 39: 495-504.
45. Jick H, Vessey MP (1978) Case-control studies in the evaluation of druginduced illness. Am J Epidemiol 107: 1-7.
46. Hackam DG, Mamdani M, Li P, Redelmeier DA (2006) Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 367: 413-418.
47. Smeeth L, Cook C, Fombonne E, Heavey L, Rodrigues LC, et al. (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364: 963-969.
48. Costanza MC (1995) Matching. Prev Med 24: 425-433.
49. Sturmer T, Brenner H (2002) Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol 155: 593-602.
50. nd ed. Modern epidemiology. Lippincott Raven. pp. 147-161.
51. Szklo MF, Nieto J (2000). Epidemiology, Beyond the Basics. Sudbury (MA): Jones and Bartlett. pp. 40-51.
52. Cole P, MacMahon B (1971) Attributable risk percent in case-control studies. Br J Prev Soc Med 25: 242-244.
53. Gissler M, Hemminki E (1996) The danger of overmatching in studies of the perinatal mortality and birthweight of infants born after assisted conception. Eur J Obstet Gynecol Reprod Biol 69: 73-75.
54. Gefeller O, Pfahlberg A, Brenner H, Windeler J (1998) An empirical investigation on matching in published case-control studies. Eur J Epidemiol 14: 321-325.
55. Artama M, Ritvanen A, Gissler M, Isojarvi J, Auvinen A (2006) Congenital structural anomalies in offspring of women with epilepsy - a population-based cohort study in Finland. Int J Epidemiol 35: 280-287.
56. Ebrahim S (2004) Cohorts, infants and children. Int J Epidemiol 33: 1165-1166.
57. Walker M, Whincup PH, Shaper AG (2004) The British Regional Heart Study 1975-2004. Int J Epidemiol 33: 1185-1192.
58. Wieland S, Dickersin K (2005) Selective exposure reporting and Medline indexing limited the search sensitivity for observational studies of the adverse effects of oral contraceptives. J Clin Epidemiol 58: 560-567.
59. Anderson HR, Atkinson RW, Peacock JL, Sweeting MJ, Marston L (2005) Ambient particulate matter and health effects: publication bias in studies of short-term associations. Epidemiology 16: 155-163.
60. Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC (2005) Habitual caffeine intake and the risk of hypertension in women. JAMA 294: 2330-2335.
61. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P (2006) Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 15: 401-402.
62. Becher H (1992) The concept of residual confounding in regression models and some applications. Stat Med 11: 1747-1758.
63. Brenner H, Blettner M (1997) Controlling for continuous confounders in epidemiologic research. Epidemiology 8: 429-434.
64. Phillips MR, Yang G, Zhang Y, Wang L, Ji H, et al. (2002) Risk factors for suicide in China: a national case-control psychological autopsy study. Lancet 360: 1728-1736.
65. Pasquale LR, Kang JH, Manson JE, Willett WC, Rosner BA, et al. (2006) Prospective study of type 2 diabetes mellitus and risk of primary openangle glaucoma in women. Ophthalmology 113: 1081-1086.
66. Craig SL, Feinstein AR (1999) Antecedent therapy versus detection bias as causes of neoplastic multimorbidity. Am J Clin Oncol 22: 51-56.
67. Rogler LH, Mroczek DK, Fellows M, Loftus ST (2001) The neglect of response bias in mental health research. J Nerv Ment Dis 189: 182-187.
68. Murphy EA (1976) The logic of medicine. Baltimore: Johns Hopkins University Press.
69. Sackett DL (1979) Bias in analytic research. J Chronic Dis 32: 51-63.
70. Johannes CB, Crawford SL, McKinlay JB (1997) Interviewer effects in a cohort study. Results from the Massachusetts Women's Health Study. Am J Epidemiol 146: 429-438.
71. Bloemenkamp KW, Rosendaal FR, Buller HR, Helmerhorst FM, Colly LP, et al. (1999) Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias. Arch Intern Med 159: 65-70.
72. Feinstein AR (1985) Clinical epidemiology: the architecture of clinical research. Philadelphia: W.B. Saunders.
73. Yadon ZE, Rodrigues LC, Davies CR, Quigley MA (2003) Indoor and peridomestic transmission of American cutaneous leishmaniasis in northwestern Argentina: a retrospective case-control study. Am J Trop Med Hyg 68: 519-526.
74. Anoop S, Saravanan B, Joseph A, Cherian A, Jacob KS (2004) Maternal depression and low maternal intelligence as risk factors for malnutrition in children: a community based case-control study from South India. Arch Dis Child 89: 325-329.
75. Carlin JB, Doyle LW (2002) Sample size. J Paediatr Child Health 38: 300-304.
76. Rigby AS, Vail A (1998) Statistical methods in epidemiology. II: A commonsense approach to sample size estimation. Disabil Rehabil 20: 405-410.
77. Schulz KF, Grimes DA (2005) Sample size calculations in randomised trials: mandatory and mystical. Lancet 365: 1348-1353.
78. Drescher K, Timm J, Jockel KH (1990) The design of case-control studies: the effect of confounding on sample size requirements. Stat Med 9: 765-776.
79. Devine OJ, Smith JM (1998) Estimating sample size for epidemiologic studies: the impact of ignoring exposure measurement uncertainty. Stat Med 17: 1375-1389.
80. Linn S, Levi L, Grunau PD, Zaidise I, Zarka S (2007) Effect measure modification and confounding of severe head injury mortality by age and multiple organ injury severity. Ann Epidemiol 17: 142-147.
81. Altman DG, Lausen B, Sauerbrei W, Schumacher M (1994) Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 86: 829-835.
82. Royston P, Altman DG, Sauerbrei W (2006) Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 25: 127-141.
83. Greenland S (1995) Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 6: 450-454.
84. Royston P, Ambler G, Sauerbrei W (1999) The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 28: 964-974.
85. MacCallum RC, Zhang S, Preacher KJ, Rucker DD (2002) On the practice of dichotomization of quantitative variables. Psychol Methods 7: 19-40.
86. Altman DG (2005) Categorizing continuous variables. In: Armitage P, Colton T editors. Encyclopedia of biostatistics. 2nd ed. Chichester: John Wiley. pp. 708-711.
87. Cohen J (1983) The cost of dichotomization. Applied Psychological Measurement 7: 249-253.
88. Zhao LP, Kolonel LN (1992) Efficiency loss from categorizing quantitative exposures into qualitative exposures in case-control studies. Am J Epidemiol 136: 464-474.
89. Cochran WG (1968) The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 24: 295-313.
90. Clayton D, Hills M (1993) Models for dose-response (Chapter 25). Statistical Models in Epidemiology. Oxford: Oxford University Press. pp. 249-260.
91. Cox DR (1957) Note on grouping. J Am Stat Assoc 52: 543-547.
92. Il'yasova D, Hertz-Picciotto I, Peters U, Berlin JA, Poole C (2005) Choice of exposure scores for categorical regression in meta-analysis: a case study of a common problem. Cancer Causes Control 16: 383-388.
93. Berglund A, Alfredsson L, Cassidy JD, Jensen I, Nygren A (2000) The association between exposure to a rear-end collision and future neck or shoulder pain: a cohort study. J Clin Epidemiol 53: 1089-1094.
94. Slama R, Werwatz A (2005) Controlling for continuous confounding factors: non- and semiparametric approaches. Rev Epidemiol Sante Publique 53 Spec No 2: 2S65-80.
95. Greenland S (1998) Introduction to regression modelling (Chapter 21). In: Rothman KJ, Greenland S editors. Modern epidemiology. 2nd ed: Lippincott Raven. pp. 401-432.
96. Thompson WD (1994) Statistical analysis of case-control studies. Epidemiol Rev 16: 33-50.
97. Schlesselman JJ (1982) Logistic regression for case-control studies (Chapter 8.2). Case-control studies Design, conduct, analysis. New York, Oxford: Oxford University Press. pp. 235-241.
98. Clayton D, Hills M (1993) Choice and interpretation of models (Chapter 27). Statistical Models in Epidemiology. Oxford: Oxford University Press. pp. 271-281.
99. Altman DG, Gore SM, Gardner MJ, Pocock SJ (1983) Statistical guidelines for contributors to medical journals. Br Med J 286: 1489-1493.
100. International Committee of Medical Journal Editors (1997) Uniform requirements for manuscripts submitted to biomedical journals [Electronic version updated February 2006, available at http://www.icmje.org/] N Engl J Med 336: 309-315.
101. Mullner M, Matthews H, Altman DG (2002) Reporting on statistical methods to adjust for confounding: a cross-sectional survey. Ann Intern Med 136: 122-126.
102. Olsen J, Basso O (1999) Re: Residual confounding. Am J Epidemiol 149: 290.
103. Hallan S, de Mutsert R, Carlsen S, Dekker FW, Aasarod K, et al. (2006) Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 47: 396-405.
104. Gotzsche PC (2006) Believability of relative risks and odds ratios in abstracts: cross sectional study. BMJ 333: 231-234.
105. Szklo MF, Nieto J (2000) Communicating Results of Epidemiologic Studies (Chapter 9). Epidemiology, Beyond the Basics. Sudbury (MA): Jones and Bartlett. pp. 408-430.
106. Chandola T, Brunner E, Marmot M (2006) Chronic stress at work and the metabolic syndrome: prospective study. BMJ 332: 521-525.
107. Vach W, Blettner M (1991) Biased estimation of the odds ratio in casecontrol studies due to the use of ad hoc methods of correcting for missing values for confounding variables. Am J Epidemiol 134: 895-907.
108. Little RJ, Rubin DB (2002) A taxonomy of missing-data methods (Chapter 1.4.) In: Statistical Analysis with Missing Data. New York: Wiley. pp. 19-23.
109. Ware JH (2003) Interpreting incomplete data in studies of diet and weight loss. N Engl J Med 348: 2136-2137.
110. Rubin DB (1976) Inference and missing data. Biometrika 63: 581-592.
111. Schafer JL (1997) Analysis of Incomplete Multivariate Data. London: Chapman & Hall.
112. Lipsitz SR, Ibrahim JG, Chen MH, Peterson H (1999) Non-ignorable missing covariates in generalized linear models. Stat Med 18: 2435-2448.
113. Rotnitzky A, Robins J (1997) Analysis of semi-parametric regression models with non-ignorable non-response. Stat Med 16: 81-102.
114. Rubin DB (1987) Multiple Imputation for Nonresponse in Surveys. New York: John Wiley.
115. Barnard J, Meng XL (1999) Applications of multiple imputation in medical studies: from AIDS to NHANES. Stat Methods Med Res 8: 17-36.
116. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, et al. (2006) Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367: 817-824.
117. Purandare N, Burns A, Daly KJ, Hardicre J, Morris J, et al. (2006) Cerebral emboli as a potential cause of Alzheimer's disease and vascular dementia: case-control study. BMJ 332: 1119-1124.
118. Steyn K, Gaziano TA, Bradshaw D, Laubscher R, Fourie J (2001) Hypertension in South African adults: results from the Demographic and Health Survey, 1998. J Hypertens 19: 1717-1725.
119. Lohr SL (1999) Design Effects (Chapter 7.5). Sampling: Design and Analysis. Pacific Grove (CA): Duxbury Press.
120. Dunn NR, Arscott A, Thorogood M (2001) The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study. Contraception 63: 65-69.
121. Rothman KJ, Greenland S (1998) Basic Methods for Sensitivity Analysis and External Adjustment. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed: Lippincott Raven. pp. 343-357.
122. Custer B, Longstreth WT Jr., Phillips LE, Koepsell TD, Van Belle G (2006) Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study. BMC Cancer 6: 152.
123. Wakefield MA, Chaloupka FJ, Kaufman NJ, Orleans CT, Barker DC, et al. (2000) Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ 321: 333-337.
124. Greenland S (2003) The impact of prior distributions for uncontrolled confounding and response bias: a case study of the relation of wire codes and magnetic fields to childhood leukemia. J Am Stat Assoc 98: 47-54.
125. Lash TL, Fink AK (2003) Semi-automated sensitivity analysis to assess systematic errors in observational data. Epidemiology 14: 451-458.
126. Phillips CV (2003) Quantifying and reporting uncertainty from systematic errors. Epidemiology 14: 459-466.
127. Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, et al. (1959) Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst 22: 173-203.
128. Langholz B (2001) Factors that explain the power line configuration wiring code-childhood leukemia association: what would they look like? Bioelectromagnetics 5: S19-31.
129. Eisner MD, Smith AK, Blanc PD (1998) Bartenders' respiratory health after establishment of smoke-free bars and taverns. JAMA 280: 1909-1914.
130. Dunne MP, Martin NG, Bailey JM, Heath AC, Bucholz KK, et al. (1997) Participation bias in a sexuality survey: psychological and behavioural characteristics of responders and non-responders. Int J Epidemiol 26: 844-854.
131. Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28: 631-639.
132. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, et al. (1995) Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev 4: 441-445.
133. Schuz J (2003) Non-response bias as a likely cause of the association between young maternal age at the time of delivery and the risk of cancer in the offspring. Paediatr Perinat Epidemiol 17: 106-112.
134. Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD (1995) Response rates among control subjects in case-control studies. Ann Epidemiol 5: 245-249.
135. Schulz KF, Grimes DA (2002) Case-control studies: research in reverse. Lancet 359: 431-434.
136. Olson SH, Voigt LF, Begg CB, Weiss NS (2002) Reporting participation in case-control studies. Epidemiology 13: 123-126.
137. Morton LM, Cahill J, Hartge P (2006) Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 163: 197-203.
138. Olson SH (2001) Reported participation in case-control studies: changes over time. Am J Epidemiol 154: 574-581.
139. Sandler DP (2002) On revealing what we'd rather hide: the problem of describing study participation. Epidemiology 13: 117.
140. Hepworth SJ, Schoemaker MJ, Muir KR, Swerdlow AJ, van Tongeren MJ, et al. (2006) Mobile phone use and risk of glioma in adults: case-control study. BMJ 332: 883-887.
141. Hay AD, Wilson A, Fahey T, Peters TJ (2003) The duration of acute cough in pre-school children presenting to primary care: a prospective cohort study. Fam Pract 20: 696-705.
142. Egger M, Juni P, Bartlett C (2001) Value of flow diagrams in reports of randomized controlled trials. JAMA 285: 1996-1999.
143. Osella AR, Misciagna G, Guerra VM, Chiloiro M, Cuppone R, et al. (2000) Hepatitis C virus (HCV) infection and liver-related mortality: a population-based cohort study in southern Italy. The Association for the Study of Liver Disease in Puglia. Int J Epidemiol 29: 922-927.
144. Dales LG, Ury HK (1978) An improper use of statistical significance testing in studying covariables. Int J Epidemiol 7: 373-375.
145. Maldonado G, Greenland S (1993) Simulation study of confounder-selection strategies. Am J Epidemiol 138: 923-936.
146. Tanis BC, van den Bosch MA, Kemmeren JM, Cats VM, Helmerhorst FM, et al. (2001) Oral contraceptives and the risk of myocardial infarction. N Engl J Med 345: 1787-1793.
147. Rothman KJ, Greenland S (1998) Precision and Validity in Epidemiologic Studies. In: Rothman KJ, Greenland S editors. Modern epidemiology. 2nd ed: Lippincott Raven. pp. 120-125.
148. Clark TG, Altman DG, De Stavola BL (2002) Quantification of the completeness of follow-up. Lancet 359: 1309-1310.
149. Qiu C, Fratiglioni L, Karp A, Winblad B, Bellander T (2004) Occupational exposure to electromagnetic fields and risk of Alzheimer's disease. Epidemiology 15: 687-694.
150. Kengeya-Kayondo JF, Kamali A, Nunn AJ, Ruberantwari A, Wagner HU, et al. (1996) Incidence of HIV-1 infection in adults and sociodemographic characteristics of seroconverters in a rural population in Uganda: 1990-1994. Int J Epidemiol 25: 1077-1082.
151. Mastrangelo G, Fedeli U, Fadda E, Valentini F, Agnesi R, et al. (2004) Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake. Environ Health Perspect 112: 1188-1192.
152. Salo PM, Arbes SJ Jr., Sever M, Jaramillo R, Cohn RD, et al. (2006) Exposure to Alternaria alternata in US homes is associated with asthma symptoms. J Allergy Clin Immunol 118: 892-898.
153. Pocock SJ, Clayton TC, Altman DG (2002) Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 359: 1686-1689.
154. Sasieni P (1992) A note on the presentation of matched case-control data. Stat Med 11: 617-620.
155. Lee GM, Neutra RR, Hristova L, Yost M, Hiatt RA (2002) A nested casecontrol study of residential and personal magnetic field measures and miscarriages. Epidemiology 13: 21-31.
156. Tiihonen J, Walhbeck K, Lonnqvist J, Klaukka T, Ioannidis JP, et al. (2006) Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 333: 224.
157. Christenfeld NJ, Sloan RP, Carroll D, Greenland S (2004) Risk factors, confounding, and the illusion of statistical control. Psychosom Med 66: 868-875.
158. Smith GD, Phillips A (1990) Declaring independence: why we should be cautious [erratum: J Epidemiol Community Health 1991 Mar;45(1);88]. J Epidemiol Community Health 44: 257-258.
159. Greenland S, Neutra R (1980) Control of confounding in the assessment of medical technology. Int J Epidemiol 9: 361-367.
160. Robins JM (2001) Data, design, and background knowledge in etiologic inference. Epidemiology 12: 313-320.
161. Sagiv SK, Tolbert PE, Altshul LM, Korrick SA (2007) Organochlorine exposures during pregnancy and infant size at birth. Epidemiology 18: 120-129.
162. World Health Organization (2007) Body Mass Index (BMI). Available: http://www.euro.who.int/nutrition/20030507_1. Accessed 10 September 2007.
163. Beral V (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419-427.
164. Hill AB (1965) The environment and disease: Association or causation? Proc R Soc Med 58: 295-300.
165. Vineis P (2003) Causality in epidemiology. Soz Praventivmed 48: 80-87.
166. Empana JP, Ducimetiere P, Arveiler D, Ferrieres J, Evans A, et al. (2003) Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 24: 1903-1911.
167. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, et al. (1999) Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353: 1547-1557.
168. Cambien F, Chretien JM, Ducimetiere P, Guize L, Richard JL (1985) Is the relationship between blood pressure and cardiovascular risk dependent on body mass index? Am J Epidemiol 122: 434-442.
169. Hosmer DW, Taber S, Lemeshow S (1991) The importance of assessing the fit of logistic regression models: a case study. Am J Public Health 81: 1630-1635.
170. Tibshirani R (1982) A plain man's guide to the proportional hazards model. Clin Invest Med 5: 63-68.
171. Rockhill B, Newman B, Weinberg C (1998) Use and misuse of population attributable fractions. Am J Public Health 88: 15-19.
172. Uter W, Pfahlberg A (2001) The application of methods to quantify attributable risk in medical practice. Stat Methods Med Res 10: 231-237.
173. Schwartz LM, Woloshin S, Dvorin EL, Welch HG (2006) Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks. BMJ 333: 1248.
174. Nakayama T, Zaman MM, Tanaka H (1998) Reporting of attributable and relative risks, 1966-97. Lancet 351: 1179.
175. Cornfield J (1951) A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst 11: 1269-1275.
176. Pearce N (1993) What does the odds ratio estimate in a case-control study? Int J Epidemiol 22: 1189-1192.
177. Rothman KJ, Greenland S (1998) Measures of Disease Frequency. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Lippincott Raven. pp. 44-45.
178. Doll R, Hill AB (2004) The mortality of doctors in relation to their smoking habits: a preliminary report. 1954. BMJ 328: 1529-1533; discussion 1533.
179. Ezzati M, Lopez AD (2003) Estimates of global mortality attributable to smoking in 2000. Lancet 362: 847-852.
180. Greenland S (1998) Applications of Stratified Analysis Methods. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Lippincott Raven. pp. 295-297.
181. Rose G (2001) Sick individuals and sick populations. Int J Epidemiol 30: 427-432; discussion 433-424.
182. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, et al. (1994) Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344: 1453-1457.
183. Botto LD, Khoury MJ (2001) Commentary: facing the challenge of geneenvironment interaction: the two-by-four table and beyond. Am J Epidemiol 153: 1016-1020.
184. Wei L, MacDonald TM, Walker BR (2004) Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 141: 764-770.
185. Martinelli I, Taioli E, Battaglioli T, Podda GM, Passamonti SM, et al. (2003) Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med 163: 2771-2774.
186. Kyzas PA, Loizou KT, Ioannidis JP (2005) Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst 97: 1043-1055.
187. Rothman KJ, Greenland S, Walker AM (1980) Concepts of interaction. Am J Epidemiol 112: 467-470.
188. Saracci R (1980) Interaction and synergism. Am J Epidemiol 112: 465-466.
189. Rothman KJ (2002) Epidemiology. An introduction. Oxford: Oxford University Press. pp. 168-180.
190. Rothman KJ (1986) Interactions Between Causes. Modern epidemiology. Boston: Little Brown. pp. 311-326.
191. Hess DR (2004) How to write an effective discussion. Respir Care 49: 1238-1241.
192. Horton R (2002) The hidden research paper. JAMA 287: 2775-2778.
193. Horton R (1995) The rhetoric of research. BMJ 310: 985-987.
194. Docherty M, Smith R (1999) The case for structuring the discussion of scientific papers. BMJ 318: 1224-1225.
195. Perneger TV, Hudelson PM (2004) Writing a research article: advice to beginners. Int J Qual Health Care 16: 191-192.
196. Annals of Internal Medicine. Information for authors. Available at: http://www.annals.org/shared/author_info.html. Accessed 10 September 2007.
197. Maldonado G, Poole C (1999) More research is needed. Ann Epidemiol 9: 17-18.
198. Phillips CV (2001) The economics of 'more research is needed'. Int J Epidemiol 30: 771-776.
199. Winkleby MA, Kraemer HC, Ahn DK, Varady AN (1998) Ethnic and socioeconomic differences in cardiovascular disease risk factors: findings for women from the Third National Health and Nutrition Examination Survey, 1988-1994. JAMA 280: 356-362.
200. Galuska DA, Will JC, Serdula MK, Ford ES (1999) Are health care professionals advising obese patients to lose weight? JAMA 282: 1576-1578.
201. Spearman C (1904) The proof and measurement of association between two things. Am J Psychol 15: 72-101.
202. Fuller WA, Hidiroglou MA (1978) Regression estimates after correcting for attenuation. J Am Stat Assoc 73: 99-104.
203. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765-774.
204. Phillips AN, Smith GD (1991) How independent are "independent" effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol 44: 1223-1231.
205. Phillips AN, Smith GD (1992) Bias in relative odds estimation owing to imprecise measurement of correlated exposures. Stat Med 11: 953-961.
206. Greenland S (1980) The effect of misclassification in the presence of covariates. Am J Epidemiol 112: 564-569.
207. Poole C, Peters U, Il'yasova D, Arab L (2003) Commentary: This study failed? Int J Epidemiol 32: 534-535.
208. Kaufman JS, Cooper RS, McGee DL (1997) Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology 8: 621-628.
209. Greenland S (1990) Randomization, statistics, and causal inference. Epidemiology 1: 421-429.
210. Taubes G (1995) Epidemiology faces its limits. Science 269: 164-169.
211. Temple R (1999) Meta-analysis and epidemiologic studies in drug development and postmarketing surveillance. JAMA 281: 841-844.
212. Greenberg RS, Shuster JL Jr. (1985) Epidemiology of cancer in children. Epidemiol Rev 7: 22-48.
213. Kushi LH, Mink PJ, Folsom AR, Anderson KE, Zheng W, et al. (1999) Prospective study of diet and ovarian cancer. Am J Epidemiol 149: 21-31.
214. Kemmeren JM, Algra A, Meijers JC, Tans G, Bouma BN, et al. (2004) Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor V Leiden mutation: a randomized trial. Blood 103: 927-933.
215. Egger M, May M, Chene G, Phillips AN, Ledergerber B, et al. (2002) Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 360: 119-129.
216. Campbell DT (1957) Factors relevant to the validity of experiments in social settings. Psychol Bull 54: 297-312.
217. Justice AC, Covinsky KE, Berlin JA (1999) Assessing the generalizability of prognostic information. Ann Intern Med 130: 515-524.
218. Krimsky S, Rothenberg LS (2001) Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 7: 205-218.
219. Bekelman JE, Li Y, Gross CP (2003) Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 289: 454-465.
220. Davidson RA (1986) Source of funding and outcome of clinical trials. J Gen Intern Med 1: 155-158.
221. Stelfox HT, Chua G, O'Rourke K, Detsky AS (1998) Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med 338: 101-106.
222. Lexchin J, Bero LA, Djulbegovic B, Clark O (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326: 1167-1170.
223. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 290: 921-928.
224. Barnes DE, Bero LA (1998) Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279: 1566-1570.
225. Barnes DE, Bero LA (1996) Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law 21: 515-542.
226. Glantz SA, Barnes DE, Bero L, Hanauer P, Slade J (1995) Looking through a keyhole at the tobacco industry. The Brown and Williamson documents. JAMA 274: 219-224.
227. Huss A, Egger M, Hug K, Huwiler-Muntener K, Roosli M (2007) Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies. Environ Health Perspect 115: 1-4.
228. Safer DJ (2002) Design and reporting modifications in industrysponsored comparative psychopharmacology trials. J Nerv Ment Dis 190: 583-592.
229. Aspinall RL, Goodman NW (1995) Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ 311: 844-846.
230. Chan AW, Hrobjartsson A, Haahr MT, Gøtzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291: 2457-2465.
231. Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B (2003) Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326: 1171-1173.
232. Scherer RW, Langenberg P, von Elm E (2005) Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: MR000005. Available: http://www.cochrane.org/reviews/en/mr000005. html. Accessed 10 September 10, 2007.
233. Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357: 1191-1194.
234. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012.
235. Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, et al. (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134: 663-694.
236. Moher D (1998) CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials. JAMA 279: 1489-1491.
237. Begg C, Cho M, Eastwood S, Horton R, Moher D, et al. (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276: 637-639.